New hope for dialysis patients: Long-Acting anemia drug under study

NCT ID NCT07136792

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new long-acting drug called pegmolesatide for anemia in people with chronic kidney disease who are on dialysis. It aims to see if switching from current anemia treatments to this drug is safe and effective. About 96 adults will receive the drug for 12 weeks and be followed for 16 weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL ANEMIA OF CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Affiliated Hospital of Zunyi Medical University

    NOT_YET_RECRUITING

    Zunyi, Guizhou, China

  • Beijing Hospital

    NOT_YET_RECRUITING

    Beijing, Beijing Municipality, China

  • CNPG Dongfeng General Hospital

    NOT_YET_RECRUITING

    Shiyan, Hubei, China

  • Changsha Central Hospital

    NOT_YET_RECRUITING

    Changsha, Hunan, China

  • Guangdong Provincial People's Hospital

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510080, China

  • Hangzhou Xiaoshan First People's Hospital

    NOT_YET_RECRUITING

    Hangzhou, Zhejiang, China

  • Jingmen Central Hospital

    NOT_YET_RECRUITING

    Jingmen, Hubei, China

  • Longyan First Hospital

    NOT_YET_RECRUITING

    Longyan, Fujian, China

  • Meizhou People's Hospital

    NOT_YET_RECRUITING

    Meizhou, Guangdong, China

  • Nantong First People's Hospital

    NOT_YET_RECRUITING

    Nantong, Jiangsu, China

  • Rui'an People's Hospital

    NOT_YET_RECRUITING

    Wenzhou, Zhejiang, China

  • The Affiliated People's Hospital of Ningbo University

    NOT_YET_RECRUITING

    Ningbo, Zhejiang, China

  • The First Affiliated Hospital of Baotou Medical College

    NOT_YET_RECRUITING

    Baotou, Neimenggu, China

  • The First Affiliated Hospital of Guangzhou Medical University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, China

  • The First Affiliated Hospital of Shandong First Medical University

    NOT_YET_RECRUITING

    Jinan, Shandong, China

  • The First Affiliated Hospital of Shantou University Medical College

    NOT_YET_RECRUITING

    Shantou, Guangdong, China

  • The First Hospital of China Medical University

    NOT_YET_RECRUITING

    Shenyang, Liaoning, China

  • Tianjin First Center Hospital

    NOT_YET_RECRUITING

    Tianjin, Tianjin Municipality, China

  • Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology

    RECRUITING

    Wuhan, Hubei, China

  • Wuhan Fourth Hospital

    NOT_YET_RECRUITING

    Wuhan, Hubei, China

  • Yibin First People's Hospital

    NOT_YET_RECRUITING

    Yibin, Sichuan, China

  • Yuebei People's Hospital

    NOT_YET_RECRUITING

    Shaoguan, Guangdong, China

  • Zhangzhou Municipal Hospital of Fujian Province

    NOT_YET_RECRUITING

    Zhangzhou, Fujian, China

  • Zhongshan Hospital of Traditional Chinese Medicine

    NOT_YET_RECRUITING

    Zhongshan, Guangdong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.